Skip to main content

The Impact of Probiotics on Antimicrobial Drugs

  • 575

    Total downloads

  • 6,945

    Total views and downloads

About this Research Topic

This Research Topic is currently accepting articles, but is closing soon.

Background

The human gut microbiota plays a crucial role in maintaining host health and modulating pharmacokinetics. Growing evidence indicates that probiotic preparations, which contain live microorganisms conferring health benefits to the host, can influence the absorption, metabolism, and excretion of various drugs. These effects may be mediated through multiple mechanisms, including modification of intestinal enzyme activity, alteration of gut permeability, competition for transporters, or indirect modulation of immune and inflammatory pathways. Despite the increasing clinical use of probiotics, their potential interactions with therapeutic agents remain poorly characterized, and the clinical relevance of these interactions is largely unexplored.

This Research Topic aims to provide a comprehensive understanding of how probiotic preparations affect drug concentrations and the incidence or severity of adverse effects. Both beneficial and detrimental interactions deserve attention: while certain probiotics may mitigate antibiotic-associated diarrhea or chemotherapy-induced mucositis, others could potentially alter systemic drug exposure and compromise therapeutic efficacy or safety. The complexity of these interactions underscores the need for interdisciplinary research integrating microbiology, pharmacology, clinical medicine, and systems biology.

We invite submissions that explore the mechanistic, preclinical, and clinical aspects of probiotic–drug interactions. Relevant studies may include, but are not limited to, the following sub-topics:

1. Mechanistic investigations of how probiotics modulate drug metabolism via microbial enzymes.

2. Experimental and clinical studies assessing changes in pharmacokinetic parameters (Cmax, AUC, clearance, etc.) associated with probiotic co-administration.

3. Investigations into the impact of probiotics on drug-induced organ toxicity, gastrointestinal side effects, or alterations in host immunity.

4. Metabolomic and microbiome-based analyses elucidating the bidirectional relationship between probiotic supplementation and xenobiotic metabolism.

5. Clinical trials evaluating the safety, efficacy, and optimal timing or formulation of probiotics when combined with antimicrobial agents, immunosuppressants, anticancer drugs, or other pharmacological classes.

This Research Topic welcomes the following articles types: FAIR² Data, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Systematic Review, Technology and Code, summarizing current evidence, as well as computational or in silico approaches that model microbiota-mediated drug transformations.

Furthermore, studies addressing regulatory and clinical implications of probiotic–drug interactions are encouraged, especially those highlighting the need for individualized therapeutic strategies considering gut microbial composition.

By consolidating insights from basic science to clinical practice, this collection will advance our understanding of the dynamic interplay between probiotics and pharmacotherapy. Ultimately, elucidating these interactions may lead to improved therapeutic outcomes, reduced adverse effects, and the rational design of microbiome-based adjunctive therapies. We hope this Research Topic will foster collaboration among microbiologists, pharmacologists, and clinicians to bridge the gap between microbiome science and precision medicine.

Research Topic Research topic image

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

  • Editorial
  • FAIR² Data
  • Hypothesis and Theory
  • Methods
  • Mini Review
  • Opinion
  • Original Research
  • Perspective
  • Review

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Keywords: probiotic preparations, antibiotics, drug-drug interaction, pharmacokinetics, pharmacodynamics

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic editors

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

  • 6,945Topic views
  • 2,889Article views
  • 575Article downloads
View impact